Latest Insider Transactions at Vor Biopharma Inc. (VOR)
This section provides a real-time view of insider transactions for Vor Biopharma Inc. (VOR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vor Biopharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vor Biopharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2021
|
Ra Capital Management, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
998,382
+26.38%
|
$42,930,426
$43.1 P/Share
|
|
Feb 09
2021
|
Tirtha Chakraborty Chief Sci Off & Head Tech Ops |
BUY
Conversion of derivative security
|
Direct |
3,534
+50.0%
|
-
|
|
Feb 09
2021
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
BUY
Conversion of derivative security
|
Direct |
3,534
+10.77%
|
-
|
|
Feb 09
2021
|
5 Am Ventures Vi, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
555,555
+10.77%
|
$9,999,990
$18.0 P/Share
|
|
Feb 09
2021
|
5 Am Ventures Vi, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,136,874
+41.01%
|
-
|
|
Feb 09
2021
|
Alexandria Venture Investments, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
282,804
+50.0%
|
-
|
|
Feb 09
2021
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
2,979,566
+16.13%
|
$53,632,188
$18.0 P/Share
|
|
Feb 09
2021
|
Ra Capital Management, L.P. |
BUY
Conversion of derivative security
|
Indirect |
7,143,025
+46.62%
|
-
|
|
Feb 09
2021
|
Kush Parmar Director |
BUY
Open market or private purchase
|
Indirect |
555,555
+10.77%
|
$9,999,990
$18.0 P/Share
|
|
Feb 09
2021
|
Kush Parmar Director |
BUY
Conversion of derivative security
|
Indirect |
6,136,874
+41.01%
|
-
|